A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT02955251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Phase 1, Open-Label, Dose-Escalation Study of ABBV-428, an Immunotherapy in Subjects With Advanced Solid Tumors
Study identification
- NCT ID
- NCT02955251
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- ABBV-428 Drug
- Nivolumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2016
- Primary completion
- Oct 28, 2019
- Completion
- Oct 28, 2019
- Last update posted
- Jul 19, 2020
2016 – 2019
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Research Institute - Pima /ID# 155461 | Scottsdale | Arizona | 85258-2345 | — |
| UC Davis Comprehensive Cancer Center - Main /ID# 154439 | Sacramento | California | 95817 | — |
| University of Chicago /ID# 154440 | Chicago | Illinois | 60637-1443 | — |
| Fox Chase Cancer Center /ID# 170665 | Philadelphia | Pennsylvania | 19111 | — |
| Greenville Hospital System /ID# 154437 | Greenville | South Carolina | 29605 | — |
| MD Anderson Cancer Center at Texas Medical Center /ID# 154441 | Houston | Texas | 77030-4000 | — |
| South Texas Accelerated Research Therapeutics /ID# 154442 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02955251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2020 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02955251 live on ClinicalTrials.gov.